Assembly Biosciences, Inc. (ASMB) is a clinical-stage biotechnology company based in South San Francisco, California, focused on developing innovative therapies for viral infections and liver diseases, with a primary emphasis on hepatitis B. Utilizing its proprietary core inhibitor platform, the company is advancing a robust pipeline of drug candidates targeting significant unmet medical needs in the treatment of chronic infections. Assembly Biosciences' commitment to redefining therapeutic approaches positions it as a unique investment opportunity for institutional investors aiming to participate in cutting-edge advancements within the biopharmaceutical sector. Show more

Location: TWO TOWER PLACE, SOUTH SAN FRANCISCO, CA, UNITED STATES, 94080, South San Francisco, CA, 94080, USA | Website: https://www.assemblybio.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

401.6M

52 Wk Range

$7.75 - $39.71

Previous Close

$25.39

Open

$25.62

Volume

56,045

Day Range

$25.58 - $26.80

Enterprise Value

198.1M

Cash

22.53M

Avg Qtr Burn

-15.13M

Insider Ownership

32.30%

Institutional Own.

56.62%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ABI-6250 Details Chronic hepatitis delta virus (HDV)	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABI-5366 Details Recurrent Genital Herpes Simplex Type 2	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABI-1179 Details Long-acting herpes simplex virus (HSV)	Phase 1b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABI-4334 Details Chronic hepatitis B virus (HBV)	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Vebicorvir (VBR, ABI-H0731) Details Liver infection, Chronic liver disease, Hepatitis B	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABI-H2158 Details Liver infection, Liver disease, Hepatitis B	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABI-H3733 Details Liver disease, Hepatitis B, Liver infection	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.